The effect of Pluronic on the protein release kinetics of an injectable drug delivery system

Journal of Controlled Release

Volumn 86, Issue 1, 2003, Pages 15-24

  DesNoyer, J R ^a   McHugh, A J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Drug delivery; Injectable depot; Phase inversion; Pluronic; Preferential segregation

Indexed keywords

1 METHYL 2 PYRROLIDINONE; COPOLYMER; M PROTEIN; MACROGOL; POLOXAMER; POLYLACTIDE; RESOMER; PROTEIN;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN SECRETION; SCANNING ELECTRON MICROSCOPY; CHEMISTRY; METHODOLOGY;

CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; POLOXAMER; PROTEINS;

EID: 0037426687     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00293-6     Document Type: Article

References (29)

1. Leong K.W., Langer R. Polymeric controlled drug delivery. Adv. Drug Deliv. Rev. 1:1987;199-233.
2. R.L. Dunn, J.P. English, D.R. Cowsar, D.P. Vanderbilt, Biodegradable in situ forming implants and methods of producing the same, US Patent 4,938,763, Jul 3, 1990.
3. R.L. Dunn, A.J. Tipton, Polymeric compositions useful as controlled release implants, US Patent 5,702,716, Dec 30, 1997.
4. Graham P.D., Brodbeck K.J., McHugh A.J. Phase inversion dynamics of PLGA solutions related to drug delivery. J. Control. Rel. 58:1999;233-245.
5. Brodbeck K.J., DesNoyer J.R., McHugh A.J. Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath side mass transfer. J. Control. Rel. 62:1999;333-344.
6. K.J. Brodbeck, A.T. Gaynor-Duarte, T.T.I. Shen, Gel composition and methods, US Patent 6,130,200, Oct 10, 2000.
7. Hester J.F., Banerjee P., Mayes A.M. Preparation of protein-resistant surfaces on poly(vinylidene fluoride) membranes via surface segregation. Macromolecules. 32:1999;1643-1650.
8. Yamaoka T., Takahashi Y., Fujisato T., Lee C.W., Tsuji T., Ohta T., Murakami A., Kimura Y. Novel adhesion prevention membrane based on a bioresorbable copoly(ester-ether) comprised of poly(L-lactide) and Pluronic: in vitro and in vivo evaluations. J. Biomed. Mater. Res. 54:2001;470-479.
9. Steinleitner A., Lambert H., Kazensky C., Cantor B. Poloxamer 407 as an intraperitoneal barrier material for the prevention of postsurgical adhesion formation and reformation in rodent models for reproductive surgery. Obstet. Gynecol. 77:1991;48-52.
10. Steinleitner A., Lopez G., Suarez M., Lambert H. An evaluation of Flowgel as an intraperitoneal barrier for prevention of postsurgical adhesion reformation. Fertil. Steril. 57:1992;305-308.
11. Leach R.E., Henry R.L. Reduction of postoperative adhesions in the rat uterine horn model with Poloxamer 407. Am. J. Obstet. Gynecol. 162:1990;1317-1319.
12. Anderson B.C., Prandit N.K., Mallapragada S.K. Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels. J. Control. Rel. 70:2001;157-167.
13. Chi S.C., Jun H.W. Release rates of ketoprofen from Poloxamer gels in a membraneless diffusion cell. J. Pharm. Sci. 80:1991;280-283.
14. Safwat S.M. Drug release from Pluronic gels. Bull. Pharm. Sci. 17:1994;41-48.
15. Yang L., Talukdar S.S., Alexandridis P. Controlled drug release from Poloxamer formulations: diffusion vs. erosion mechanism. Polym. Prepr. 40:1999;347-348.
16. Gilbert J.C., Hadgraft J., Bye A., Brookes L.G. Drug release from Pluronic F127 gels. Int. J. Pharm. 32:1986;233-238.
17. Moore T., Croy S., Mallapragada S., Pandit N. Experimental investigation and mathematical modeling of Pluronic F127 gel dissolution: drug release in stirred systems. J. Control. Rel. 67:2000;191-202.
18. Blanco D., Alonso M.J. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres. Effect of the protein and polymer properties and the co-encapsulation of surfactants. Eur. J. Pharm. Biopharm. 45:1998;285-294.
19. Huatan H., Collet J.H., Attwood D., Booth C. Preparation and characterization of poly(ε-caprolactone) polymer blends for delivery of proteins. Biomaterials. 16:1995;1297-1303.
20. Carrasquillo K.G., Stanley A.M., Aponte-Carro J.C., De Jesus P., Costantino H.R., Bosques C.J., Griebenow K. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J. Control. Rel. 76:2001;199-208.
21. Tobio M., Nolley J., Guo Y., McIver J., Alonso M.J. A novel system based on a Poloxamer/PLGA blend as a tetanus toxoid delivery vehicle. Pharm. Res. 16:1999;682-688.
22. Park T.G., Cohen S., Langer R. Poly(L-lactic acid)/Pluronic blends: characterization of phase separation behavior, degradation, and morphology and use as protein-releasing matrixes. Macromolecules. 25:1992;116-122.
23. T.G. Park, S. Cohen, R. Langer, Controlled drug delivery using polymer-Pluronic blends, US Patent 5,330,768, Jul 19, 1994.
24. Gates K.A., Grad H., Birek P., Lee P.I. A new bioerodible polymer insert for the controlled release of metronidazole. Pharm. Res. 11:1994;1605-1609.
25. Ash M. Pharmaceutical Additives Electronic Handbook, Synapse Information Resources, Inc. 1996;Gower Publishing, Brookfield, Vermont.
26. Takadate A., Irikura M., Suehiro T., Fujino H., Goya S. New labeling reagents for alcohols in fluorescence high-performance chromatography. Chem. Pharm. Bull. 33:1985;1164-1169.
27. J.R. DesNoyer, The Role of Phase Inversion in the Drug Release Kinetics in Injectable Polymer Solutions, Doctoral thesis, University of Illinois, Urbana, IL, 2002.
28. Ravi Kumar M.N.V. Nano and microparticles as controlled drug delivery devices. J. Pharm. Pharmaceut. Sci. 3:2000;234-258.
29. Furness E.L., Ross A., Davis T.P., King G.C. A hydrophobic interaction site for lysozyme binding to polyethylene glycol and model contact lens polymers. Biomaterials. 19:1998;1361-1369.